| Print
RESVERLOGIX CORP. (RVX)
EquityThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.
Address
202, 279 Midpark Way SE
Calgary
AB
CAN
T2X 1M2
Telephone
+1 403 2549252
Forecast key dates
| Name | Key Date |
|---|---|
| Resverlogix Corp Third Quarter Earnings Results for 2026 | 2026-11-13T00:00:00 |
| Resverlogix Corp Second Quarter Earnings Results for 2026 | 2026-08-14T00:00:00 |
| Resverlogix Corp Annual General Meeting for 2026 | 2026-06-30T13:00:00 |
| Resverlogix Corp First Quarter Earnings Results for 2026 | 2026-05-14T00:00:00 |
| Resverlogix Corp Fourth Quarter Earnings Results for 2025 | 2026-04-01T00:00:00 |
| Resverlogix Corp Annual Report for 2025 | 2026-03-31T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Resverlogix Corp Third Quarter Earnings Results for 2025 | 2025-11-13T00:00:00 |
| Resverlogix Corp Second Quarter Earnings Results for 2025 | 2025-08-14T00:00:00 |
| Resverlogix Corp Annual General Meeting for 2025 | 2025-06-30T13:00:00 |
| Resverlogix Corp First Quarter Earnings Results for 2025 | 2025-05-14T00:00:00 |
| Resverlogix Corp Fourth Quarter Earnings Results for 2024 | 2025-04-01T00:00:00 |
| Resverlogix Corp Annual Report for 2024 | 2025-03-31T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.